Progressive with Okinus used creative financing to open an account in my husband's name after he was denied from the one company. Not only that my contract per month which is on my phone now ...

Australia-listed Anson Resources has received approval for a modified royalty structure on its lithium lease in Utah, which ...

As conservatives target library content and funding across the country, bookworms and librarians are teaming up in a ...

As conservatives target library content and funding across the country, bookworms and librarians are teaming up in a California beach town to take their case to voters.

Progressive Democrats are on a tear. The party liberals — particularly younger voices, in Congress and outside of it — are increasingly disillusioned with how the Democrats’ old guard is ...

It operates through two segments: Progressive Leasing and Vive. The company owns Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider ...

The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review ...

Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today reported its business highlights ...

BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the first quarter ended March 31, 2025, ...

The board also gave unanimous approval to a lease plan that will allow the nonprofit Grid Alternatives to build a community solar farm on a 7.5-acre portion of metro district property located a ...

An employee at Putnam City North has been placed on administrative leave following allegations of a potential violation of the Student Communication Act, the district says. The district says the ...

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.